| 1 |
35108536 | Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry. | 2022 Feb 1 |
3 |
| 2 |
35228534 | High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers. | 2022 Feb 28 |
1 |
| 3 |
35279348 | Glycans in HIV-1 vaccine design - engaging the shield. | 2022 Mar 9 |
2 |
| 4 |
35354052 | Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans. | 2022 Mar 29 |
2 |
| 5 |
35401559 | High-Throughput B Cell Epitope Determination by Next-Generation Sequencing. | 2022 |
2 |
| 6 |
35475646 | Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies. | 2022 Apr 27 |
1 |
| 7 |
32949621 | Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop. | 2021 Jan |
5 |
| 8 |
33826885 | Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike. | 2021 Apr 6 |
1 |
| 9 |
34019795 | Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. | 2021 May 27 |
2 |
| 10 |
34160251 | Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth. | 2021 Aug 10 |
2 |
| 11 |
34559854 | Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma. | 2021 Sep |
1 |
| 12 |
34659153 | The Role of L-Selectin in HIV Infection. | 2021 |
1 |
| 13 |
32669335 | A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. | 2020 Sep 15 |
1 |
| 14 |
32675574 | Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies. | 2020 Sep |
1 |
| 15 |
32926485 | Roles of variable linker length in dual acting virucidal entry inhibitors on HIV-1 potency via on-the-fly free energy molecular simulations. | 2020 Nov |
1 |
| 16 |
32938661 | A VH1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite. | 2020 Sep |
2 |
| 17 |
33057580 | Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate. | 2020 Nov 13 |
2 |
| 18 |
33084569 | A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch. | 2020 Oct 21 |
3 |
| 19 |
33093196 | Visualization of the HIV-1 Env glycan shield across scales. | 2020 Nov 10 |
8 |
| 20 |
33205023 | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies. | 2020 Nov 20 |
13 |
| 21 |
33319171 | Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail. | 2020 Dec 18 |
3 |
| 22 |
33388127 | Synthetic carbohydrate-based HIV-1 vaccines. | 2020 Dec |
1 |
| 23 |
31028779 | Protein and Glycan Mimicry in HIV Vaccine Design. | 2019 May 31 |
3 |
| 24 |
31126879 | Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. | 2019 Jun 18 |
1 |
| 25 |
31607367 | Antibody responses to the HIV-1 envelope high mannose patch. | 2019 |
8 |
| 26 |
31841553 | Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans. | 2019 Dec |
5 |
| 27 |
29420040 | Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. | 2018 Mar 2 |
3 |
| 28 |
29474444 | Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. | 2018 Feb |
2 |
| 29 |
29677181 | Exploiting glycan topography for computational design of Env glycoprotein antigenicity. | 2018 Apr |
2 |
| 30 |
30134158 | Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen. | 2018 Aug 21 |
3 |
| 31 |
30355496 | Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth. | 2018 Oct 23 |
1 |
| 32 |
30395637 | HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. | 2018 Nov |
2 |
| 33 |
28133813 | The HIV-1 envelope glycoprotein structure: nailing down a moving target. | 2017 Jan |
2 |
| 34 |
28202756 | Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers. | 2017 May 1 |
1 |
| 35 |
28249163 | Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates. | 2017 Feb 28 |
1 |
| 36 |
28348411 | Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. | 2017 Mar 28 |
3 |
| 37 |
28363124 | Structural principles controlling HIV envelope glycosylation. | 2017 Jun |
1 |
| 38 |
28423342 | A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure. | 2017 Apr 18 |
1 |
| 39 |
28548638 | Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies. | 2017 May 26 |
2 |
| 40 |
28667249 | Conformational Heterogeneity of the HIV Envelope Glycan Shield. | 2017 Jun 30 |
1 |
| 41 |
26762799 | Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities. | 2016 Feb 17 |
1 |
| 42 |
26766578 | Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort. | 2016 Jan |
1 |
| 43 |
27438765 | A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans. | 2016 Jul 19 |
4 |
| 44 |
27489265 | Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. | 2016 Oct 15 |
3 |
| 45 |
27617431 | Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. | 2016 Oct |
1 |
| 46 |
27707925 | HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual. | 2016 Dec 15 |
4 |
| 47 |
25985274 | Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth. | 2015 Jun |
2 |
| 48 |
26018173 | Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140. | 2015 Aug |
1 |
| 49 |
26051934 | Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers. | 2015 Jun 16 |
3 |
| 50 |
26085151 | Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope. | 2015 Sep |
2 |